daunorubicin has been researched along with AIDS-Associated Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fätkenheuer, G; Goekbuget, N; Hentrich, M; Hoelzer, D; Hoffmann, C; Horst, HA; Jaeger, H; Noppeney, R; Plettenberg, A; Stellbrink, HJ; Stoehr, A; Van Lunzen, J; Wolf, E; Wyen, C | 1 |
1 other study(ies) available for daunorubicin and AIDS-Associated Lymphoma
Article | Year |
---|---|
AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Lymphoma, AIDS-Related; Male; Mercaptopurine; Prednisolone; Prednisone; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |